Showing results 14 to 23 of 23
< previous
| Issue Date | Title | Author(s) |
| 30-Jan-2023 | Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets | Ragusa, D; Dijkhuis, L; Pina, C; Tosi, S |
| 26-Feb-2021 | MYB oncoproteins: emerging players and potential therapeutic targets in human cancer | Cicirò, Y; Sala, A |
| 7-Dec-2018 | Overview of Cell Signaling Pathways in Cancer | Harvey, AJ |
| 9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
| 28-May-2021 | Phosphorylation and stabilization of PIN1 by JNK promote intrahepatic cholangiocarcinoma growth | Lepore, A; Choy, PM; Lee, NCW; Carella, MA; Favicchio, R; Briones‐Orta, MA; Glaser, SS; Alpini, G; D’Santos, C; Tooze, RM; Lorger, M; Syn, W; Papakyriakou, A; Giamas, G; Bubici, C; Papa, S |
| 19-Jan-2020 | Prognostic Value of Complement Properdin in Cancer | Mangogna, A; Varghese, PM; Agostinis, C; Alrokayan, SH; Khan, HA; Stover, CM; Belmonte, B; Martorana, A; Ricci, G; Bulla, R; Kishore, U |
| 13-Aug-2022 | Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent | Fraser, CR; Ajenjo, J; Veal, M; Dias, GM; Chan, C; O’Neill, E; Destro, G; Lau, D; Pacelli, A; Gouverneur, V; Hueting, R; Cornelissen, B |
| 10-Mar-2022 | Risk adjustment in audit of outcome after head and neck surgery applied to cumulative sum chart methodology to monitor of free flap failure | Tighe, DF; McMahon, J; Ho, M; Sassoon, I |
| 9-Jul-2023 | RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines | Zoroddu, S; Sanna, L; Bordoni, V; Lyu, W; Murineddu, G; Pinna, GA; Forcales, SV; Sala, A; Kelvin, DJ; Bagella, L |
| 3-Aug-2024 | The role of diet in cancer: the potential of shaping public policy and clinical outcomes in the UK | Britten, O; Tosi, S |
